Companies: 10,795·Total market cap: $144.5T

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd.

CANFAMEXHealthcare● Active

$3.09

+$0.00(+0.00%)

Market Cap$1662420

P/E Ratio—

52W High$23.4

52W Low$2.83

Avg Volume519K

Open$3.12

Beta0.01

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Can-Fite BioPharma Ltd.（CANF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CANF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.90Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)560000.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding823,926Shares outstanding history

Next EarningsAug 27, 2026Est.Earnings history

探索 Can-Fite BioPharma Ltd. 数据

分析师预测$5 · Buy

股息不分红

营收$408212-39.43%

盈利EPS $-12.03-1013.89%

财务快照

FY 2025Revenue$408212.00▼ 39.43% YoY

202320242025

FY 2025Net Income-$9.9M▼ 25.71% YoY

202320242025

FY 2025EPS$-12.03▼ 1013.89% YoY

202320242025

TTM:Revenue: $560000.00Net Income: -$8.8MEPS: $-0.90View income statement →

分析师评级与目标价

Buy4 位分析师

Strong Buy

0

Buy

3

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$5.00Low

$3.09Current

$5.00Avg Target上涨空间 61.81%

$5.00High

合计: 4 · 买入占比: 75.0%

根据过去 3 个月内 4 位华尔街分析师，CANF 共识评级为 Buy，12 个月平均目标价 $5.00 （较现价 $3.09 上涨空间 61.81%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Can-Fite BioPharma Ltd.

$3.09+0.00%$1.7M #2

Biodexa Pharmaceuticals Plc

$3.38+0.30%$56,618.1 #3

Calidi Biotherapeutics, Inc.

$0.17+3.20%$1.3M #4

Clearmind Medicine Inc.

$3.74-3.77%$3.8M #5

CNS Pharmaceuticals, Inc.

$5.03+2.10%$2.9M #6

$2.19+9.88%$196,283

股票表现

1D+0.00%

1W-2.22%

1M-11.97%

3M-32.09%

YTD-22.75%

1Y-86.08%

5Y-99.29%

关于 Can-Fite BioPharma Ltd.

CEOPnina Fishman

IPO DateNov 6, 2012

Employees5

CountryIL

Websitecanfite.com

Can-Fite BioPharma Ltd. a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. Th…

Biotechnology HealthcareAMEXADRIL

关于股票概览与关键数据

Can-Fite BioPharma Ltd.（CANF）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 6, 2012 在 AMEX 上市。截至最近交易日，CANF 股价为 $3.09，市值约为 $1.7M。过去12个月累计回报 -86.08%，年初至今回报 -22.75%。

根据 4 位华尔街分析师，Can-Fite BioPharma Ltd. 股票共识评级为Buy，12个月平均目标价为 $5.00。2025 财年 Can-Fite BioPharma Ltd. 营收 $408212.00，净利润 -$9.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Can-Fite BioPharma Ltd.（CANF）股价为 $3.09，在 AMEX 上市，52周区间为 $2.83 – $23.40。

CANF 最新股价CANF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议